The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DNA Diagnostics & Testing Market Research Report 2025
Synopsis
The global DNA Diagnostics & Testing market was valued at US$ 10260 million in 2023 and is anticipated to reach US$ 10120 million by 2030, witnessing a CAGR of -0.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Diagnostics & Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Diagnostics & Testing.
Report Scope
The DNA Diagnostics & Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Diagnostics & Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Diagnostics & Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Segment by Type
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Segment by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Diagnostics & Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global DNA Diagnostics & Testing market was valued at US$ 10260 million in 2023 and is anticipated to reach US$ 10120 million by 2030, witnessing a CAGR of -0.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Diagnostics & Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Diagnostics & Testing.
Report Scope
The DNA Diagnostics & Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Diagnostics & Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Diagnostics & Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Segment by Type
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Segment by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Diagnostics & Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Diagnostics & Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR Based Diagnostics
1.2.3 NGS DNA Diagnosis
1.2.4 In-situ Hybridization Diagnostics
1.2.5 Micro-arrays Based Diagnostics
1.3 Market by Application
1.3.1 Global DNA Diagnostics & Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology Diagnostics & Histopathology
1.3.3 Identity Diagnostics & Forensics
1.3.4 Pharmacogenomics Diagnostic Testing & Drug Metabolism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Diagnostics & Testing Market Perspective (2019-2030)
2.2 DNA Diagnostics & Testing Growth Trends by Region
2.2.1 Global DNA Diagnostics & Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 DNA Diagnostics & Testing Historic Market Size by Region (2019-2024)
2.2.3 DNA Diagnostics & Testing Forecasted Market Size by Region (2025-2030)
2.3 DNA Diagnostics & Testing Market Dynamics
2.3.1 DNA Diagnostics & Testing Industry Trends
2.3.2 DNA Diagnostics & Testing Market Drivers
2.3.3 DNA Diagnostics & Testing Market Challenges
2.3.4 DNA Diagnostics & Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Diagnostics & Testing Players by Revenue
3.1.1 Global Top DNA Diagnostics & Testing Players by Revenue (2019-2024)
3.1.2 Global DNA Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global DNA Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by DNA Diagnostics & Testing Revenue
3.4 Global DNA Diagnostics & Testing Market Concentration Ratio
3.4.1 Global DNA Diagnostics & Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Diagnostics & Testing Revenue in 2023
3.5 DNA Diagnostics & Testing Key Players Head office and Area Served
3.6 Key Players DNA Diagnostics & Testing Product Solution and Service
3.7 Date of Enter into DNA Diagnostics & Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Diagnostics & Testing Breakdown Data by Type
4.1 Global DNA Diagnostics & Testing Historic Market Size by Type (2019-2024)
4.2 Global DNA Diagnostics & Testing Forecasted Market Size by Type (2025-2030)
5 DNA Diagnostics & Testing Breakdown Data by Application
5.1 Global DNA Diagnostics & Testing Historic Market Size by Application (2019-2024)
5.2 Global DNA Diagnostics & Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America DNA Diagnostics & Testing Market Size (2019-2030)
6.2 North America DNA Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America DNA Diagnostics & Testing Market Size by Country (2019-2024)
6.4 North America DNA Diagnostics & Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Diagnostics & Testing Market Size (2019-2030)
7.2 Europe DNA Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe DNA Diagnostics & Testing Market Size by Country (2019-2024)
7.4 Europe DNA Diagnostics & Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Diagnostics & Testing Market Size (2019-2030)
8.2 Asia-Pacific DNA Diagnostics & Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific DNA Diagnostics & Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific DNA Diagnostics & Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Diagnostics & Testing Market Size (2019-2030)
9.2 Latin America DNA Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America DNA Diagnostics & Testing Market Size by Country (2019-2024)
9.4 Latin America DNA Diagnostics & Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Diagnostics & Testing Market Size (2019-2030)
10.2 Middle East & Africa DNA Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa DNA Diagnostics & Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa DNA Diagnostics & Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories DNA Diagnostics & Testing Introduction
11.1.4 Abbott Laboratories Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Detail
11.2.2 Affymetrix Inc. Business Overview
11.2.3 Affymetrix Inc. DNA Diagnostics & Testing Introduction
11.2.4 Affymetrix Inc. Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.2.5 Affymetrix Inc. Recent Development
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Detail
11.3.2 Agilent Technologies Inc Business Overview
11.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Introduction
11.3.4 Agilent Technologies Inc Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.3.5 Agilent Technologies Inc Recent Development
11.4 Applied Biosystems Group
11.4.1 Applied Biosystems Group Company Detail
11.4.2 Applied Biosystems Group Business Overview
11.4.3 Applied Biosystems Group DNA Diagnostics & Testing Introduction
11.4.4 Applied Biosystems Group Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.4.5 Applied Biosystems Group Recent Development
11.5 Illumina Inc.
11.5.1 Illumina Inc. Company Detail
11.5.2 Illumina Inc. Business Overview
11.5.3 Illumina Inc. DNA Diagnostics & Testing Introduction
11.5.4 Illumina Inc. Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.5.5 Illumina Inc. Recent Development
11.6 Cepheid Inc.
11.6.1 Cepheid Inc. Company Detail
11.6.2 Cepheid Inc. Business Overview
11.6.3 Cepheid Inc. DNA Diagnostics & Testing Introduction
11.6.4 Cepheid Inc. Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.6.5 Cepheid Inc. Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic DNA Diagnostics & Testing Introduction
11.7.4 Hologic Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.7.5 Hologic Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Dako
11.9.1 Dako Company Detail
11.9.2 Dako Business Overview
11.9.3 Dako DNA Diagnostics & Testing Introduction
11.9.4 Dako Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.9.5 Dako Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott DNA Diagnostics & Testing Introduction
11.10.4 Abbott Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.10.5 Abbott Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Detail
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics DNA Diagnostics & Testing Introduction
11.11.4 Roche Diagnostics Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.11.5 Roche Diagnostics Recent Development
11.12 Beckman Coulter Inc.
11.12.1 Beckman Coulter Inc. Company Detail
11.12.2 Beckman Coulter Inc. Business Overview
11.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Introduction
11.12.4 Beckman Coulter Inc. Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.12.5 Beckman Coulter Inc. Recent Development
11.13 Siemens Healthcare
11.13.1 Siemens Healthcare Company Detail
11.13.2 Siemens Healthcare Business Overview
11.13.3 Siemens Healthcare DNA Diagnostics & Testing Introduction
11.13.4 Siemens Healthcare Revenue in DNA Diagnostics & Testing Business (2019-2024)
11.13.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
